News

Bausch + Lomb presented several product innovations in pharmaceuticals, OTC offerings, IOLs, and surgical devices and equipment during the annual meeting of the American Academy of Ophthalmology.

David E.I. Pyott, Allergan’s board chairman and chief executive officer (CEO) has been ranked the 4th best-performing CEO in the world by the Harvard Business Review.

The results of the largest retrospective study of multiple sclerosis (MS) in uveitis patients has revealed that nearly 60% of patients with both diseases were diagnosed with each within a 5-year span.

Ophthalmology Times is pleased to announce the winner of the 2014 Resident Writers Award Program, sponsored by Allergan.

A joint reception hosted by Ophthalmic Women Leaders (OWL) and Women in Ophthalmology (WIO) featured the presentation of the Suzanne Veronneau-Troutman Award to an outstanding female ophthalmologist. In addition, a panel discussion focused on the importance of working together across diverse professional disciplines in the eye-care field.

When misalignment of a toric IOL underlies a suboptimal outcome and the problem is identified during early postoperative follow-up, surgeons should not procrastinate about taking the patient back to the operating room for a repositioning procedure, said Roger F. Steinert, MD.

Data reported by American surgeons using ocriplasmin for treatment of symptomatic vitreomacular adhesion (VMA) show that it is possible to increase the success rate through careful patient selection, said David Chow, MD.

Reading speed is reduced in patients with glaucomatous visual field loss and normal visual acuity, and the reduction in performance is directly proportional to the extent of the visual field loss, said Aron Guimaraes, MD.

Sen. Rand Paul (R-KY) could not have been happier to be back among his fellow ophthalmologists while discussing his views on healthcare.

Results from a retrospective, nonrandomized study show a strong association between donor history of diabetes and Descemet membrane endothelial keratoplasty (DMEK) graft preparation failure, said Mark A. Greiner, MD.

TearScience introduced its new LipiView II system that assists clinicians in improving diagnosis of meibomian gland dysfunction (MGD) with objective examination of patients’ tear film lipid layer, blink profile, and now meibomian gland structure and function.

Sightpath Medical announced a significant milestone-improving the sight of 2 million eyes.

Patients who undergo second eye cataract surgery benefit with improvements in visual function and quality of life to levels beyond those obtained after first eye cataract surgery, said Nakul Shekhawat, MD.

Ellex Medical Lasers Ltd. has released a comprehensive e-book-“It’s All About Outflow”-describing the role of canaloplasty in clinical practice.

Results of a retrospective cohort analysis including data from more than 129,000 eyes that underwent clear corneal phacoemulsification reinforce the efficacy of intracameral antibiotic injection for preventing postoperative endophthalmitis, said Neil Shorstein, MD.

Findings from a mid-term evaluation of the first Descemet Membrane Endothelial Keratoplasty (DMEK) cohort show that the procedure results in a near complete visual recovery that is achieved at 6 months and seems to remain stable for at least up to 6 years, said Fook Chang Lam, MD.

Electronic Health Records, the Affordable Care Act, and Meaningful Use. The ophthalmology profession has seen its fair share of challenges over the past year, but Gregory L. Skuta, MD said despite these complications, the field has made great achievements and has had many successes.

Evidence for assessing the efficacy and safety of anti-vascular endothelial growth factor (VEGF) agents for treating corneal and ocular surface disease is accumulating. However, there is clearly a need for more research to define if, when, and how this therapy should be used, said Anat Galor, MD.

A targeted approach to treatment based on the findings of a thorough history, appropriate testing, and clinical exam can be successful for bringing relief to many patients with dry eye that is difficult to manage, said Deepinder K. Dhaliwal, MD.

Heidelberg Engineering GmbH announces an ophthalmic picture archiving and communication system (PACS) platform.

As more state legislatures are relaxing anti-marijuana laws, doctors are being put in the middle by patients requesting prescriptions or authorizations for its use for medical needs, said Marc F. Lieberman, MD.

OCULUS Surgical launched ImproVue ophthalmic lubricant drops for topical use to hydrate and lubricate the outer surface of the eye.

There has been considerable progress in treatment for diabetic macular edema (DME) in the last several years, but a look at the investigational pipeline indicates further advances are likely on the horizon, said Peter A. Campochiaro, MD.

It is with great excitement that we unveil our network-wide redesign. Please read further to learn more about a few of our new features, and browse around to explore the new site!

Although the prognosis for posterior uveal melanoma remains poor, a look at recent developments and ongoing research provides hope for better outcomes in the future, said Jerry A. Shields, MD, in his delivery of the 2014 Charles L. Schepens, MD, Lecture.

Results from 1 year of follow-up show that transepithelial corneal crosslinking (CXL) with iontophoresis appears to be safe and effective in arresting the progression of keratoconus, said Paolo Vinciguerra, MD.

Abbott and Carl Zeiss Meditec announced that they have entered into a non-exclusive commercial collaboration in the United States.

There are already several good reasons for ophthalmic surgeons to perform “heads-up” surgery. Further benefits to support its use are anticipated as the technology continues to evolve, said Claus Eckardt, MD, professor of ophthalmology, Klinikum Frankfurt Höchst, Frankfurt, Germany.

Preliminary results from the Patient Reported Outcomes with LASIK-1 (PROWL-1) and PROWL-2 studies show that at 3 months after surgery, more than 95% of patients are seeing 20/20 or better uncorrected binocularly and more than 90% have monocular uncorrected visual acuity of 20/20 or better, said Malvina B. Eydelman, MD.

A novel medical device from BlephEx allows physicians to perform a painless, in-office procedure to treat blepharitis-thus relieving patients from the chronic and irritating symptoms of inflammatory lid disease and dry eye.